Depression and Anxiety Trial, Recruiting (NCT07576686)

Depression and Anxiety Trial, Recruiting NCT07576686 Sponsor: Aleksandra Stojanovic Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07576686 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have been diagnosed with mild depression and/or an anxiety disorder, confirmed through a structured clinical interview
People who are able to understand the study information and agree to take part
People who have access to a device such as a computer, tablet, or smartphone that can run the digital platform used in the study
People who are willing to take part in weekly sessions over a 10-week period

Who may not be able to join:

People with moderate to severe depression
People who have currently or have previously been diagnosed with a psychotic disorder
People who have been diagnosed with bipolar disorder
People with a substance use disorder or dependence
People whose primary diagnosis is antisocial personality disorder
People with severe difficulties with thinking, memory, or concentration, or who are unable to use digital tools
People who are currently at acute (immediate) risk of suicide requiring urgent care
People who are currently taking part in another structured talking therapy program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +381642293541

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07576686

Sponsor: Aleksandra Stojanovic

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: +381642293541

More information: https://clinicaltrials.gov/study/NCT07576686

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have been diagnosed with mild depression and/or an anxiety disorder, confirmed through a structured clinical interview
People who are able to understand the study information and agree to take part
People who have access to a device such as a computer, tablet, or smartphone that can run the digital platform used in the study
People who are willing to take part in weekly sessions over a 10-week period

Who may not be able to join:

People with moderate to severe depression
People who have currently or have previously been diagnosed with a psychotic disorder
People who have been diagnosed with bipolar disorder
People with a substance use disorder or dependence
People whose primary diagnosis is antisocial personality disorder
People with severe difficulties with thinking, memory, or concentration, or who are unable to use digital tools
People who are currently at acute (immediate) risk of suicide requiring urgent care
People who are currently taking part in another structured talking therapy program

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Aleksandra Stojanovic

Registry

ClinicalTrials.gov

Start date

7 January 2026

Est. completion

15 May 2026

Where this trial is recruiting

🇷🇸 Serbia

Primary endpoints

Change in depressive symptom severity; Change in anxiety symptom severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov